| 000 | 01744 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517162824.0 | ||
| 264 | 0 | _c20180730 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-017-5969-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAjmani, Gaurav S | |
| 245 | 0 | 0 |
_aThe Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cOct 2017 |
||
| 300 |
_a3157-3166 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Lobular _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHospitals, High-Volume _xstatistics & numerical data |
| 650 | 0 | 4 |
_aHospitals, Low-Volume _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aJames, Ted A | |
| 700 | 1 | _aKantor, Olga | |
| 700 | 1 | _aWang, Chi-Hsiung | |
| 700 | 1 | _aYao, Katharine A | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 24 _gno. 11 _gp. 3157-3166 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-017-5969-1 _zAvailable from publisher's website |
| 999 |
_c27345962 _d27345962 |
||